๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

TPSTMa circulating tumor marker in breast cancer

โœ Scribed by Roland Einarsson


Publisher
Association of Clinical Biochemistry of India
Year
1999
Tongue
English
Weight
543 KB
Volume
14
Category
Article
ISSN
0970-1915

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Circulating tumour markers in breast can
โœ Ettore Seregni; Antonio Coli; Nicola Mazzucca; Italian Group RIA-IRMA Test, Ital ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Springer ๐ŸŒ English โš– 146 KB
Role of tumor marker in breast cancer
โœ P. Stieber; M. Untch; H. Sauer ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Springer ๐ŸŒ German โš– 418 KB
Tumor marker kinetics in the monitoring
โœ David T. Kiang; Leonard J. Greenberg; B. J. Kennedy ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 600 KB

Controversy exists in using carcinoembryonic antigen (CEA) for monitoring the clinical course of breast cancer. In this study, the kinetics of two plasma tumor markers, CEA and CA15-3, immediately after the initiation of chemotherapy were assessed in 30 patients with advanced breast cancer. Four dis

Carcinoembryonic antigen and interferon
โœ Yoav Horn; Dalia Hacohen; Jacob L. Zeidman; Natalio Walach; Sally Sharf; Adi Hel ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval